TORS as a Primary Treatment Modality in the Treatment of HPV-Related Oral Pharynx Cancers

Carole Fakhry

Carole Fakhry M.D.
Associate Professor of Otolaryngology - Head and Neck Surgery

Expertise: Cancer of Unknown Primary, Head and Neck Cancers, Human Papillomavirus Infections, Hyperparathyroidism, Laryngeal Cancer, Neck Masses, Oropharynx Cancers, Otolaryngology, Parathyroid Diseases, Parathyroid Surgery, Pharynx Cancer, Skin Cancer, Thyroid Cancer, Thyroid Diseases, Tongue Cancer, Tonsil Cancer, Transoral robotic surgery (TORS)   Research Interests: HPV-associated head and neck squamous cell cancer View full profile

More Information

What kind of information would you like to request?     More Information       Make a Referral

Leave this field empty

Otolaryngologist Carole Fakhry, M.D., discusses the use of transoral robotic surgery (TORS) in the treatment of HPV-related oral pharynx cancer, and how its use can de-intensify and reduce morbidities from typically used adjuvant treatment therapies.

Comments